A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer

NCT02901483 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped bussiness reason

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: PEP503
DRUG: Cisplatin
RADIATION: Radiotherapy

Sponsor

PharmaEngine